Racial differences and an increased systemic inflammatory response are seen in patients with COVID-19 and ischemic

Chen Lin1, Yurany A Arevalo1, Hely D Nanavati2

  • 1Department of Neurology, The University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Insights

COVID-19 significantly increases ischemic stroke severity and mortality, particularly in African Americans. An elevated neutrophil-to-lymphocyte ratio (NLR) indicates a heightened inflammatory response associated with worse outcomes in stroke patients with COVID-19.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Novel coronavirus disease 2019 (COVID-19) has been associated with various neurological complications.
  • Ischemic stroke is a serious potential complication, and its clinical presentation in the context of COVID-19 requires further elucidation, particularly regarding racial disparities and inflammatory markers.

Purpose of the Study:

  • To compare the clinical presentation of ischemic stroke in patients with and without COVID-19, focusing on racial differences.
  • To investigate the association between the inflammatory response, specifically the neutrophil-to-lymphocyte ratio (NLR), and stroke severity in patients with COVID-19.

Main Methods:

  • A retrospective, observational, cross-sectional study was conducted on 60 patients admitted with ischemic stroke.
  • Patients were tested for COVID-19 upon admission, and demographic, clinical, and laboratory data were collected.
  • Descriptive statistics were used to compare stroke patients with and without COVID-19.

Main Results:

  • Nine out of 60 patients tested positive for COVID-19.
  • African Americans represented a higher proportion of stroke patients with COVID-19 (55.6%) compared to those without (37.7%).
  • COVID-19 positive stroke patients exhibited significantly higher NIH Stroke Scale (NIHSS) scores and NLR compared to COVID-19 negative patients. Mortality rates were substantially higher in the COVID-19 positive group (44.4% vs. 7.6%).

Conclusions:

  • Ischemic stroke patients with COVID-19, including a notable proportion of African Americans, presented with increased severity.
  • An exaggerated inflammatory response, indicated by elevated NLR, is likely linked to greater stroke severity in patients with concurrent COVID-19 and ischemic stroke.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
240
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
243
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
290
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.3K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
239